Citation Impact
Citing Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
2005 Standout
The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteins
2013 StandoutScienceNobel
Loss of cryptochrome reduces cancer risk in p53 mutant mice
2009 StandoutNobel
Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression
2010 StandoutNobel
Randomized Phase II Trial Comparing Bevacizumab Plus Carboplatin and Paclitaxel With Carboplatin and Paclitaxel Alone in Previously Untreated Locally Advanced or Metastatic Non-Small-Cell Lung Cancer
2004 Standout
Hypoxia-inducible factors and RAB22A mediate formation of microvesicles that stimulate breast cancer invasion and metastasis
2014 StandoutNobel
Genetic evidence for a tumor suppressor role of HIF-2α
2005
Activation of the HIF pathway in cancer
2001
Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition
2006 StandoutNobel
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
2009 StandoutNobel
The impact of O2 availability on human cancer
2008
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Probing p53 biological functions through the use of genetically engineered mouse models
2005
The role of microvessel density on the survival of patients with lung cancer: a systematic review of the literature with meta-analysis
2002
C. elegans EGL-9 and Mammalian Homologs Define a Family of Dioxygenases that Regulate HIF by Prolyl Hydroxylation
2001 StandoutNobel
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
HIF-1 and tumor progression: pathophysiology and therapeutics
2002 StandoutNobel
AKT/PKB Signaling: Navigating Downstream
2007 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Ranibizumab for Neovascular Age-Related Macular Degeneration
2006 Standout
Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer
2004 Standout
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
2012 StandoutNatureNobel
High‐temperature beverages and foods and esophageal cancer risk—A systematic review
2009
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Development and Disease in Proteinase-Deficient Mice
1998
Paclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
2006 Standout
Angiogenesis in cancer and other diseases
2000 StandoutNature
A New Weapon for Attacking Tumor Blood Vessels
2008 StandoutNobel
Insulin-like Growth Factor 1 Induces Hypoxia-inducible Factor 1-mediated Vascular Endothelial Growth Factor Expression, Which is Dependent on MAP Kinase and Phosphatidylinositol 3-Kinase Signaling in Colon Cancer Cells
2002 StandoutNobel
Age-dependent Defect in Vascular Endothelial Growth Factor Expression Is Associated with Reduced Hypoxia-inducible Factor 1 Activity
2000 StandoutNobel
Global cancer statistics
2011 Standout
Vascular Endothelial Growth Factor: Molecular and Biological Aspects
1999
Differential Function of the Prolyl Hydroxylases PHD1, PHD2, and PHD3 in the Regulation of Hypoxia-inducible Factor
2004 StandoutNobel
Regulation of angiogenesis by hypoxia: role of the HIF system
2003 StandoutNobel
Angiogenesis in life, disease and medicine
2005 StandoutNature
A role for hypoxia and hypoxia-inducible transcription factors in tumor physiology
2002
Hypoxia in cancer: significance and impact on clinical outcome
2007 Standout
Hypoxia Rescues Frataxin Loss by Restoring Iron Sulfur Cluster Biogenesis
2019 StandoutNobel
Oxidants, oxidative stress and the biology of ageing
2000 StandoutNature
Vascular-specific growth factors and blood vessel formation
2000 StandoutNature
Vessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinoma
1998
B7-H4 (DD-O110) is overexpressed in high risk uterine endometrioid adenocarcinomas and inversely correlated with tumor T-cell infiltration
2007
Genetic analysis of ageing: role of oxidative damage and environmental stresses
1996
Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets?
2003
Tea drinking habits and oesophageal cancer in a high risk area in northern Iran: population based case-control study
2009
Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1α
1998 StandoutNobel
Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: correlation with clinicopathology and patient survival, and analysis of serum VEGF levels
1997
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
2004 Standout
Carbon Monoxide and Nitric Oxide Suppress the Hypoxic Induction of Vascular Endothelial Growth Factor Gene via the 5′ Enhancer
1998 StandoutNobel
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
2011 StandoutNobel
Evaluation of HIF-1 inhibitors as anticancer agents
2007 StandoutNobel
Angiogenesis as a therapeutic target
2005 StandoutNature
The p66shc adaptor protein controls oxidative stress response and life span in mammals
1999 StandoutNature
Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth
2008 StandoutNobel
Vascular Endothelial Growth Factor: Basic Science and Clinical Progress
2004 Standout
Circulating insulin-like growth factor-I levels regulate colon cancer growth and metastasis.
2002
Physiology meets biophysics: Visualizing the interaction of hypoxia-inducible factor 1α with p300 and CBP
2002 StandoutNobel
VEGF and VEGF type C play an important role in angiogenesis and lymphangiogenesis in human malignant mesothelioma tumours
1999
Hypoxia-inducible factor 1 is a master regulator of breast cancer metastatic niche formation
2011 StandoutNobel
The Biology of Vascular Endothelial Growth Factor
1997 Standout
BET bromodomain inhibition targets both c-Myc and IL7R in high-risk acute lymphoblastic leukemia
2012
Vessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
1999 StandoutScience
Preclinical Safety Evaluation of rhuMAbVEGF, an Antiangiogenic Humanized Monoclonal Antibody
1999
Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate
1998
Kinase requirements in human cells: III. Altered kinase requirements inVHL−/− cancer cells detected in a pilot synthetic lethal screen
2008 StandoutNobel
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
2012 StandoutNobel
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Peptide blockade of HIFα degradation modulates cellular metabolism and angiogenesis
2002 StandoutNobel
Cloning and characterization of a functional human homolog of Escherichia coli endonuclease III
1997 StandoutNobel
Vascular Endothelial Growth Factor 189 mRNA Isoform Expression Specifically Correlates With Tumor Angiogenesis, Patient Survival, and Postoperative Relapse in Non–Small-Cell Lung Cancer
2001
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.
1997
Global cancer statistics, 2012
2015 Standout
Hypoxia-inducible factor-dependent signaling between triple-negative breast cancer cells and mesenchymal stem cells promotes macrophage recruitment
2014 StandoutNobel
Works of Reet Koomägi being referenced
Prognostic value of vascular endothelial growth factor and its receptor Flt-1 in squamous cell lung cancer
1997
Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma
1996
Heat shock (hsp70) and resistance proteins in non-small cell lung carcinomas
1995
Tissue-factor expression in human non-small-cell lung carcinoma measured by immunohistochemistry: Correlation between tissue factor and angiogenesis
1998
Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug response in vitro.
1997
Prognostic relevance of c-Myc and caspase-3 for patients with non-small cell lung cancer.
2000
UV-induced DNA damage and mutations in Hupki (human p53 knock-in) mice recapitulate p53 hotspot alterations in sun-exposed human skin.
2001
Hypoxia-inducible factor (HIF-1) and its relationship to apoptosis and proliferation in lung cancer.
2000
Unusual profile and high prevalence of p53 mutations in esophageal squamous cell carcinomas from northern Iran.
2001
Relationship between the expression of caspase-3 and the clinical outcome of patients with non-small cell lung cancer.
2000
VASCULAR ENDOTHELIAL GROWTH-FACTOR EXPRESSION AND ANGIOGENESIS IN NONSMALL CELL LUNG CARCINOMAS
1995
nm23-H1 protein expression in newly diagnosed and relapsed childhood acute lymphoblastic leukemia.
1999